Greenwich LifeSciences, Inc. earnings per share and revenue
On 14 de nov. de 2025, GLSI reported earnings of -0.30 USD per share (EPS) for Q3 25, beating the estimate of -0.30 USD, resulting in a 0.30% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.08% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.34 USD, with revenue projected to reach -- USD, implying an aumentar of 13.33% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Greenwich LifeSciences, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Greenwich LifeSciences, Inc. reported EPS of -$0.30, missing estimates by 0.3%, and revenue of $0.00, 0% as expectations.
How did the market react to Greenwich LifeSciences, Inc.'s Q3 2025 earnings?
The stock price moved down -1.08%, changed from $8.32 before the earnings release to $8.23 the day after.
When is Greenwich LifeSciences, Inc. expected to report next?
The next earning report is scheduled for 13 de abr. de 2026.
What are the forecasts for Greenwich LifeSciences, Inc.'s next earnings report?
Based on 3
analistas, Greenwich LifeSciences, Inc. is expected to report EPS of -$0.34 and revenue of -- for Q4 2025.